19th May 2016 15:30
For immediate release
Circassia Pharmaceuticals plc
Appointment of Broker
19 May 2016
Circassia Pharmaceuticals plc (LSE: CIR) announces that it has appointed Numis Securities Limited as joint broker to the Company, alongside JP Morgan Cazenove, with immediate effect.
- Ends -
Enquiries
Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications
|
Tel: +44 (0)1865 405 560 |
Numis Securities Clare Terlouw / Michael Meade
| Tel: +44 (0) 20 7260 1000 |
JP Morgan Cazenove James Mitford / James Deal
| Tel: +44 (0) 20 7742 4000 |
FTI Consulting Ben Atwell / Simon Conway / Mo Noonan | Tel: +44 (0) 20 3727 1000 |
Related Shares:
CIR.L